STOCK TITAN

Canopy Growth (NASDAQ: CGC) secures $162M loan, swaps debt terms

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Canopy Growth Corporation entered into a new senior secured loan and completed a major debt exchange and warrant issuance. The company received US$150,000,000 of cash proceeds under a senior secured loan with aggregate principal of US$162,115,000, funded with an original issue discount of US$12,115,000. The loan bears interest at Term SOFR (floor 3.25%) plus 6.25%, matures as late as January 31, 2031, and is secured by substantially all assets of the company and its material subsidiaries. Canopy plans to use the net proceeds to repay approximately US$101 million of existing senior secured debt, and for working capital, general corporate purposes, and potential future acquisitions.

In connection with this financing, the company issued 18,705,577 common share purchase warrants exercisable at US$1.30 per share for five years. Separately, Canopy exchanged C$96,358,375 of existing senior unsecured convertible debentures maturing in May 2029 for new convertible debentures with principal of C$55,000,000 maturing on July 8, 2031, plus 12,731,481 warrants at C$2.16 per share, 9,493,670 common shares, and a C$10,500,000 cash payment. The new debentures bear 7.50% annual interest and are convertible at C$1.83 per share, with a forced conversion feature if the Toronto Stock Exchange average closing price exceeds C$2.75 for 10 consecutive trading days. The company also amended its arrangement agreement with MTL Cannabis Corp. to refine how in-the-money MTL warrants are treated, requiring a cashless exercise notice to receive shares; otherwise, warrants are exchanged for replacement warrants on Canopy common shares.

Positive

  • None.

Negative

  • None.

Insights

Canopy Growth refinances debt with a large secured loan, warrant package and debenture exchange, extending maturities but adding secured leverage and potential dilution.

Canopy Growth Corporation arranged a senior secured loan with aggregate principal of US$162,115,000, advancing US$150,000,000 in cash after an original issue discount of US$12,115,000. The loan bears interest at Term SOFR, subject to a 3.25% floor, plus a 6.25% margin, and includes an exit fee of US$6,484,600 and make-whole provisions for early repayment in the first year. It is secured by substantially all assets of the company and its material subsidiaries and requires minimum cash equal to the lesser of US$90,000,000 or the loan principal.

The company intends to use net proceeds to repay approximately US$101 million of existing senior secured debt under a prior credit agreement, while also funding working capital, general corporate purposes, and potential acquisitions. This shifts the capital structure toward a single, larger secured facility with a final maturity as late as January 31, 2031, and optional monthly principal repayments of up to US$3,000,000 per lender after the first interest anniversary.

To compensate lenders, Canopy issued 18,705,577 common share purchase warrants exercisable at US$1.30 per share for five years and agreed to register the underlying shares for resale within 30 days of the loan closing date. Separately, it exchanged C$96,358,375 of 2029-maturity debentures for new C$55,000,000 debentures due July 8, 2031, 12,731,481 warrants at C$2.16, 9,493,670 common shares, and C$10,500,000 cash. The new debentures carry a 7.50% coupon, semi-annual cash interest, conversion at C$1.83 per share, and a forced conversion trigger if the Toronto Stock Exchange average closing price exceeds C$2.75 for 10 consecutive trading days.

The transactions collectively extend debt maturities and standardize terms but introduce meaningful warrant overhang and potential equity issuance through conversion features and warrant exercises. An amended plan of arrangement with MTL Cannabis Corp. adjusts how in-the-money MTL warrants are treated, requiring an MTL warrant exercise notice two business days before the arrangement effective date to receive shares via cashless exercise; otherwise, such warrants are exchanged for replacement warrants on Canopy common shares. Future disclosures in company filings may provide additional detail on how these terms affect leverage, interest expense, and equity dilution over time.

false 0001737927 Canopy Growth Corp 00-0000000 0001737927 2026-01-06 2026-01-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): January 6, 2026

 

 

 

Canopy Growth Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Canada   001-38496   N/A
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

1 Hershey Drive
Smiths Falls, Ontario
K7A 0A8
(Address of principal executive officers) (Zip Code)

 

(855) 558-9333

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange
on which registered
Common Shares, no par value   CGC   Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company    ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

 

Item 1.01Entry into a Material Definitive Agreement.

 

Loan Agreement

 

On January 8, 2026, Canopy Growth Corporation (the “Company”) entered into a Loan and Guaranty Agreement (the “Loan Agreement”), by and among the Company, as a borrower, certain subsidiaries of the Company party thereto, as borrowers and/or guarantors, the parties identified therein as lenders (the “Lenders”), and JGB Collateral LLC, as administrative and collateral agent (the “Agent”), pursuant to which, among other things, the Lenders advanced US$150,000,000 pursuant to a senior secured loan in the aggregate principal amount of US$162,115,000 (collectively, the “Loans” and such transaction, the “Loan Transaction”). The Loans were funded on January 8, 2026 (the “Loan Closing Date”) with an original issue discount of US$12,115,000. The Loans will mature on the earlier of (i) January 31, 2031, and (ii) the date that is 120 days prior to the maturity date of the Convertible Debentures (as defined below).

 

The outstanding principal amount of the Loans will bear interest at an annual rate equal to the applicable Term SOFR rate (subject to a minimum floor of 3.25%) plus 6.25%. Interest on the Loans will be paid monthly in arrears in cash. Following the first anniversary of the first interest payment date, each Lender will have the option to require the borrowers to repay such Lender its pro rata share of up to US$3,000,000 of principal per calendar month on each payment date thereafter. Prepayment and repayment of the Loans will be subject to (i) an interest make-whole equal to 12 monthly interest payments less any payments made by the borrowers on account of interest prior to the date of such prepayment for any prepayments or repayments made during the first year of the Loans and (ii) an exit fee equal to US$6,484,600, provided that, with respect to any partial payment of the Loans, only the pro rata portion of such exit fee will be payable at the time of each such partial payment. The Loans and obligations under the Loan Agreement and other related loan documents will be secured by substantially all of the assets of the Company and each of its material subsidiaries.

 

The Loan Agreement also includes certain prepayment fees, a minimum cash requirement of the lesser of US$90,000,000 or the principal amount of the Loans, and various other representations, warranties, covenants and events of default customary for a financing of this nature. The Company intends to use the net proceeds from the Loans to (i) repay its existing senior secured debt in the principal amount of approximately US$101 million pursuant to its credit agreement, dated March 18, 2021 among, the Company and the other parties named therein (as amended, restated, supplemented or otherwise modified from time to time); (ii) for working capital and general corporate purposes; and (iii) to fund any potential future acquisitions.

 

In connection with the Loan Agreement, on the Loan Closing Date, the Company issued 18,705,577 common share purchase warrants of the Company (the “Loan Warrants”) to the Lenders. Each Loan Warrant will entitle the holder to acquire one common share of the Company (each, a “Common Share”) at an exercise price equal to US$1.30 per Common Share for a period of five years from the Loan Closing Date.

 

In connection with the Loan Transaction, on January 8, 2026, the Company entered into a registration rights agreement (the “Lender Registration Rights Agreement”) with the Lenders, pursuant to which the Company agreed to file a registration statement with the Securities and Exchange Commission (the “SEC”) to register for resale the Common Shares underlying the Loan Warrants (the “Loan Warrant Shares”) within 30 days after the Loan Closing Date (the “Loan Filing Deadline”).

 

The foregoing descriptions of the Loan Agreement, the Lender Registration Rights Agreement and the Loan Warrants do not purport to be complete and are qualified in their entirety by reference to the full text of such agreements, which are attached to this Current Report on Form 8-K (“Current Report”) as Exhibit 10.1, 10.2 and 4.1, respectively, and are incorporated herein by reference.

 

1

 

Exchange Agreement

 

On January 7, 2026, the Company entered into an Exchange Agreement (the “Exchange Agreement”) with MMCAP International Inc. SPC (the “Investor”) pursuant to which, among other things, on January 8, 2026 (the “Exchange Closing Date”), the Investor delivered to the Company C$96,358,375 aggregate principal amount of senior unsecured convertible debentures of the Company maturing in May 2029 held by the Investor in exchange for (A) the Company issuing to the Investor (i) new senior unsecured convertible debentures of the Company with an aggregate principal amount of C$55,000,000 maturing on July 8, 2031 (the “Convertible Debentures”), (ii) 12,731,481 common share purchase warrants (the “Investor Warrants” and together with the Loan Warrants, the “Warrants”) of the Company, and (iii) 9,493,670 Common Shares (the “Exchange Shares”) and (B) a C$10,500,000 cash payment from the Company (collectively, the “Exchange Transaction” and together with the Loan Transaction, the “Transactions”). Each Investor Warrant will entitle the holder to acquire one Common Share at an exercise price equal to C$2.16 per Common Share and will expire on January 8, 2031. The Convertible Debentures will bear interest at a rate of 7.50% per annum, payable in semi-annual payments in cash, and will be convertible, at the option of the Investor, into Common Shares at a conversion price equal to C$1.83 per Common Share. The Convertible Debentures, the Common Shares underlying the Convertible Debenture (the “Debenture Shares”), the Warrants, the Loan Warrant Shares and the Common Shares underlying the Investor Warrants (the “Investor Warrant Shares”) are collectively referred to herein as the “Securities.” The Exchange Agreement includes standard representations, warranties and covenants of the Company and the Investor.

 

The Convertible Debentures will be subject to a forced conversion feature upon notice from the Company in the event that the average closing trading price of the Common Shares on the Toronto Stock Exchange exceeds C$2.75 for a period of 10 consecutive trading days.

 

In connection with the Exchange Transaction, on January 8, 2026, the Company entered into a registration rights agreement (the “Investor Registration Rights Agreement”) with the Investor, pursuant to which the Company agreed to file a registration statement with the SEC to register for resale the Exchange Shares, the Debenture Shares and the Investor Warrant Shares within three business days after the Exchange Closing Date.

 

The foregoing descriptions of the Convertible Debentures, the Investor Warrants, the Exchange Agreement and the Investor Registration Rights Agreement do not purport to be complete and are qualified by reference to the full text of such agreements, which are attached to this Current Report as Exhibits 4.2, 4.3, 10.3 and 10.4, respectively, and are incorporated herein by reference.

 

Item 2.03Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information set forth in Item 1.01 of this Current Report under “Loan Agreement” and “Exchange Agreement” relating to the Loan Transaction and the Exchange Transaction, respectively, is incorporated by reference into this Item 2.03.

 

Item 3.02Unregistered Sales of Equity Securities

 

The information set forth in Item 1.01 of this Current Report under “Loan Agreement” and “Exchange Agreement” is incorporated by reference into this Item 3.02. The offer and sale of the Loans and the Securities were made in reliance on the exemption from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”).

 

Item 7.01Regulation FD Disclosure.

 

On January 8, 2026, the Company issued a press release (the “Press Release”) to announce the Transactions. A copy of the Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

The information set forth and incorporated by reference in Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information set forth and incorporated by reference in Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, shall not be incorporated by reference into any filing under the Securities Act or the Exchange Act, regardless of any incorporation by reference language in any such filing.

 

Item 8.01Other Events.

 

Amendment to Arrangement Agreement with MTL Cannabis Corp.

 

2

 

As previously disclosed, on December 14, 2025, the Company entered into an arrangement agreement (the “Arrangement Agreement”) with MTL Cannabis Corp. (“MTL”) pursuant to which, among other things, the Company agreed to acquire all of the issued and outstanding common shares in the capital of MTL (the “MTL Shares”) by way of a plan of arrangement under the Canada Business Corporations Act (the “Arrangement”). The Plan of Arrangement attached as Schedule A to Arrangement Agreement (the “Original Plan of Arrangement”) provided, among other things, that, at the effective time of the Arrangement (the “Effective Time”), each outstanding MTL warrant (an “MTL Warrant”) that is in-the-money (an “MTL In-The-Money-Warrant”) would be deemed to be exercised on a cashless basis and surrendered and forfeited by the holder thereof to MTL (free and clear of any liens of any nature whatsoever), and would be exchanged for MTL Shares, having a fair market value equal to the amount by which the relevant MTL In-The-Money-Warrant is in the money, less any amounts withheld pursuant to the terms of the Arrangement.

 

On January 6, 2026, the Company and MTL entered into an Amending Agreement to the Arrangement Agreement, (the “Amendment”) which amended the Original Plan of Arrangement (the “Amended Plan of Arrangement”). The Amended Plan of Arrangement provides that, an MTL Warrant that is in-the-money will be deemed to be an MTL In-The-Money-Warrant if the holder duly delivers to MTL a written notice of cashless exercise two business days in advance of the effective date of the Arrangement (an “MTL Warrant Exercise Notice”), and, in the event that an MTL Warrant Exercise Notice is not duly delivered, such MTL Warrant will be deemed to be an out-of-the-money MTL Warrant (an “MTL Out-Of-The-Money Warrant”) and will be exchanged for a replacement warrant to purchase Common Shares on the same terms as replacement warrants will be granted to other holders of MTL Out-Of-The-Money Warrants in accordance with the Amended Plan of Arrangement. For greater certainty, an MTL In-The-Money Warrant for which an MTL Warrant Exercise Notice is duly delivered, will be treated as all MTL In-The-Money Warrants were treated under the Original Plan of Arrangement prior to the Amendment, as described in the preceding paragraph. Other than the foregoing, the Amended Plan of Arrangement is the same as the Original Plan of Arrangement.

 

Item 9.01Financial Statements and Exhibits.

 

(d) Exhibits

 

     
Exhibit
No.
  Exhibit Description
   
4.1   Form of Loan Warrant Certificate
4.2   Convertible Debenture Certificate
4.3   Form of Investor Warrant Certificate
10.1   Loan and Guaranty Agreement, dated as of January 8, 2026, by and among the Company, as borrower, the subsidiaries of the Company party thereto as borrowers or guarantors, the parties identified therein as lenders, and JGB Collateral LLC, as administrative agent.
10.2   Registration Rights Agreement, dated as of January 8, 2026, by and between the Company and the Lenders
10.3   Exchange Agreement, dated as of January 7, 2026, by and between the Company and MMCAP International Inc. SPC
10.4   Registration Rights Agreement, dated as of January 8, 2026, by and between the Company and MMCAP International Inc. SPC
99.1   Press release, dated January 8, 2026
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

3

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CANOPY GROWTH CORPORATION
     
  By: /s/ Thomas Stewart
    Thomas Stewart
    Chief Financial Officer

 

Date: January 8, 2026

 

4

 

FAQ

What new loan did Canopy Growth Corporation (CGC) enter into?

Canopy Growth entered into a Loan and Guaranty Agreement under which lenders advanced US$150,000,000 pursuant to a senior secured loan with aggregate principal of US$162,115,000. The loan bears interest at Term SOFR (with a 3.25% floor) plus 6.25% and can mature as late as January 31, 2031.

How will Canopy Growth use the proceeds from the new senior secured loan?

The company intends to use the net proceeds to repay approximately US$101 million of existing senior secured debt under a March 18, 2021 credit agreement, and for working capital, general corporate purposes, and potential future acquisitions.

What warrants did Canopy Growth issue in connection with the loan transaction?

Canopy Growth issued 18,705,577 common share purchase warrants to the lenders. Each warrant entitles the holder to buy one common share at an exercise price of US$1.30 per share for five years from the loan closing date.

What are the key terms of Canopy Growth’s new convertible debentures from the exchange transaction?

In the exchange with MMCAP International Inc. SPC, Canopy issued senior unsecured convertible debentures with principal of C$55,000,000 maturing on July 8, 2031, bearing 7.50% annual interest, payable semi-annually in cash, and convertible at C$1.83 per common share.

What did the investor receive in the exchange for existing debentures?

The investor delivered C$96,358,375 principal amount of existing debentures and received new convertible debentures of C$55,000,000, 12,731,481 common share purchase warrants at C$2.16 per share, 9,493,670 common shares, and a C$10,500,000 cash payment.

How can the new convertible debentures be forcibly converted into Canopy Growth shares?

The convertible debentures are subject to forced conversion upon notice from the company if the average closing trading price of the common shares on the Toronto Stock Exchange exceeds C$2.75 for 10 consecutive trading days.

What change did Canopy Growth make to its arrangement with MTL Cannabis Corp.?

The company and MTL amended their plan of arrangement so that an in-the-money MTL warrant is treated as such only if the holder delivers an MTL warrant exercise notice two business days before the effective date. Otherwise, the warrant is deemed out-of-the-money and is exchanged for a replacement warrant to purchase Canopy common shares on specified terms.

Canopy Growth Corp

NASDAQ:CGC

CGC Rankings

CGC Latest News

CGC Latest SEC Filings

CGC Stock Data

449.66M
351.06M
0.07%
7.26%
6.76%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
SMITH FALLS